AIMS: As obesity-related cardiovascular mortality, although elevated when compared with normal weight, is lower in females than in males at every body mass index (BMI) level, we aimed to investigate gender-specific differences in left ventricular (LV) hypertrophy in obesity, which themselves have been shown to have varying prognostic value. METHOD AND RESULTS: In total, 741 subjects (female, n = 399) without identifiable cardiovascular risk factors (BMI 15.7-59.2 kg/m(2)) underwent cardiovascular magnetic resonance (1.5 T) to determine LV mass, end-diastolic volume (EDV, mL), and LV mass/volume ratio (LVM/VR). Across both sexes, there was a strong positive correlation between BMI and LV mass (male r = 0.44, female r = 0.57, both P < 0.001), with males showing a greater LV hypertrophic response (male +2.3 vs. female +1.6 g per BMI point increase, P = 0.001). Concentric hypertrophy was present in both sexes and LVM/VR positively correlated to BMI (male r = 0.45, female r = 0.29, both P < 0.001) on linear regression analysis. However, the degree of concentric hypertrophy was greater in males (male +0.13 vs. female +0.06 LVM/VR increase per BMI point increase, P = 0.001). On the other hand, females showed a greater LV cavity dilatory response (female +1.1 vs. male +0.3 mL per BMI point increase, P < 0.001). Indeed, in contrast to females, where BMI and LV-EDV were positively correlated (r = 0.38, P < 0.001), BMI did not correlate with EDV in men (r = 0.03, P = 0.62). CONCLUSION: In the absence of traditional cardiovascular risk factors, obese men show predominantly concentric hypertrophy, whereas obese women exhibit both eccentric and concentric hypertrophy. As concentric hypertrophy is more strongly related to cardiovascular mortality than eccentric hypertrophy, our observations may explain the observed gender difference in obesity-related mortality.
AIMS: As obesity-related cardiovascular mortality, although elevated when compared with normal weight, is lower in females than in males at every body mass index (BMI) level, we aimed to investigate gender-specific differences in left ventricular (LV) hypertrophy in obesity, which themselves have been shown to have varying prognostic value. METHOD AND RESULTS: In total, 741 subjects (female, n = 399) without identifiable cardiovascular risk factors (BMI 15.7-59.2 kg/m(2)) underwent cardiovascular magnetic resonance (1.5 T) to determine LV mass, end-diastolic volume (EDV, mL), and LV mass/volume ratio (LVM/VR). Across both sexes, there was a strong positive correlation between BMI and LV mass (male r = 0.44, female r = 0.57, both P < 0.001), with males showing a greater LV hypertrophic response (male +2.3 vs. female +1.6 g per BMI point increase, P = 0.001). Concentric hypertrophy was present in both sexes and LVM/VR positively correlated to BMI (male r = 0.45, female r = 0.29, both P < 0.001) on linear regression analysis. However, the degree of concentric hypertrophy was greater in males (male +0.13 vs. female +0.06 LVM/VR increase per BMI point increase, P = 0.001). On the other hand, females showed a greater LV cavity dilatory response (female +1.1 vs. male +0.3 mL per BMI point increase, P < 0.001). Indeed, in contrast to females, where BMI and LV-EDV were positively correlated (r = 0.38, P < 0.001), BMI did not correlate with EDV in men (r = 0.03, P = 0.62). CONCLUSION: In the absence of traditional cardiovascular risk factors, obese men show predominantly concentric hypertrophy, whereas obese women exhibit both eccentric and concentric hypertrophy. As concentric hypertrophy is more strongly related to cardiovascular mortality than eccentric hypertrophy, our observations may explain the observed gender difference in obesity-related mortality.
Authors: Oliver J Rider; Steffen E Petersen; Jane M Francis; Mohammed K Ali; Lucy E Hudsmith; Monique R Robinson; Kieran Clarke; Stefan Neubauer Journal: Heart Date: 2010-05-18 Impact factor: 5.994
Authors: Sandeep Dhindsa; Michael G Miller; Cecilia L McWhirter; Donald E Mager; Husam Ghanim; Ajay Chaudhuri; Paresh Dandona Journal: Diabetes Care Date: 2010-03-03 Impact factor: 19.112
Authors: G de Simone; R B Devereux; M J Roman; A Ganau; S Chien; M H Alderman; S Atlas; J H Laragh Journal: Am J Cardiol Date: 1991-12-15 Impact factor: 2.778
Authors: Cesare Russo; Fusako Sera; Zhezhen Jin; Vittorio Palmieri; Shunichi Homma; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Marco R Di Tullio Journal: Eur J Heart Fail Date: 2016-04-24 Impact factor: 15.534
Authors: Anderson C Armstrong; David R Jacobs; Samuel S Gidding; Laura A Colangelo; Ola Gjesdal; Cora E Lewis; Kirsten Bibbins-Domingo; Stephen Sidney; Pamela J Schreiner; O D Williams; David C Goff; Kiang Liu; Joao A C Lima Journal: Int J Cardiol Date: 2014-01-16 Impact factor: 4.164
Authors: Yu Wang; Robin Shoemaker; David Powell; Wen Su; Sean Thatcher; Lisa Cassis Journal: Am J Physiol Heart Circ Physiol Date: 2016-12-16 Impact factor: 4.733
Authors: L Rodríguez; F Detomaso; P Braga; M Prendes; F Perosi; G Cernadas; A Balaszczuk; A Fellet Journal: J Endocrinol Invest Date: 2015-02-21 Impact factor: 4.256
Authors: Oliver J Rider; Ezimamaka Ajufo; Mohammed K Ali; Steffen E Petersen; Richard Nethononda; Jane M Francis; Stefan Neubauer Journal: Int J Cardiovasc Imaging Date: 2014-10-11 Impact factor: 2.357